Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Akanda Corp ( (AKAN) ) is now available.
On December 18, 2025, Akanda Corp. publicly welcomed reports that U.S. President Donald Trump’s administration is considering federal cannabis policy reforms, including potentially moving cannabis from Schedule I to Schedule III, a category that recognizes medical value and lower abuse potential. Interim CEO Katie Field said that a science-led, public-health approach to cannabis in the United States could accelerate medical research, improve consumer safety and further shift demand from illicit markets to regulated channels, echoing elements of Canada’s own Cannabis Act framework introduced in 2018. The company urged U.S. policymakers to keep any reforms focused on measurable outcomes such as expanding medical research, protecting public health, fostering responsible regulation and curbing illicit supply, signaling Akanda’s interest in a more mature and harmonized North American cannabis landscape that could strengthen regulated industry participants over time.
More about Akanda Corp
Akanda Corp. is a Toronto-based cannabis company operating through subsidiaries in Canada, focused on cultivating and distributing high-quality cannabis and wellness products. The company aims to provide safe, reliable and accessible cannabis offerings to consumers globally, while emphasizing sustainable business practices in the regulated cannabis market.
Average Trading Volume: 3,441,491
Technical Sentiment Signal: Sell
Current Market Cap: $542.6K
For an in-depth examination of AKAN stock, go to TipRanks’ Overview page.